Nifty
:
11930.35
Sensex
:
40685.50
33.90 (0.28%)
127.01 (0.31%)
Nifty
Sensex
:
:
11930.35
40685.50
33.90 (0.28%)
127.01 (0.31%)

Pharmaceuticals & Drugs

Rating :
66/99  (View)

BSE: 500009 | NSE: AMBASARABH

NSE BSE
17.65
-0.75 (-4.08%)
23-Oct-2020 | 4:01PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  18.90
  •  18.95
  •  17.50
  •  18.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  105875
  •  18.69
  •  30.95
  •  9.95

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 135.26
  • 9.39
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 143.72
  • N/A
  • 3.04

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 30.76%
  • 20.61%
  • 46.15%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 2.48%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.32
  • 0.23
  • 2.22

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -20.83
  • -31.60
  • -30.53

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -20.34
  • 142.70

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 1.42
  • 18.47

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.85
  • 2.70
  • 3.86

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.29
  • 1.01
  • -0.34

Quarterly Results

Consolidated Figures in Rs. Crores /

Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
27
31
-14%
39
45
-14%
32
37
-14%
32
34
-6%
Expenses
27
32
-17%
37
42
-11%
33
35
-3%
33
34
-2%
EBITDA
0
-1
-
1
3
-51%
-2
2
-
-1
1
-
EBIDTM
0%
-4%
4%
6%
-5%
6%
-2%
2%
Other Income
2
3
-46%
16
2
756%
3
1
162%
2
1
101%
Interest
1
1
-12%
1
1
49%
1
1
-53%
1
1
65%
Depreciation
1
1
27%
1
1
91%
1
1
-2%
0
1
-2%
PBT
0
0
27%
15
4
337%
1
2
-67%
0
1
-75%
Tax
0
0
-
1
2
-56%
0
0
-
0
1
-
PAT
0
0
-
14
1
1276%
1
2
-62%
0
0
-
PATM
-1%
1%
37%
2%
2%
5%
1%
-1%
EPS
-0.03
0.02
-
1.87
0.14
1236%
0.08
0.23
-65%
0.04
-0.06
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
129
134
152
125
134
132
124
105
100
89
80
Net Sales Growth
-12%
-12%
22%
-7%
1%
6%
19%
4%
13%
12%
 
Cost Of Goods Sold
76
79
90
70
77
73
73
58
54
52
50
Gross Profit
53
54
62
55
57
59
52
47
46
37
29
GP Margin
41%
41%
41%
44%
43%
45%
42%
44%
46%
42%
37%
Total Expenditure
130
135
146
137
145
145
129
113
111
101
99
Power & Fuel Cost
-
3
3
3
3
4
3
2
3
2
2
% Of Sales
-
2%
2%
2%
2%
3%
2%
2%
3%
2%
3%
Employee Cost
-
27
26
27
29
31
28
27
30
27
26
% Of Sales
-
20%
17%
21%
21%
24%
23%
26%
30%
30%
32%
Manufacturing Exp.
-
4
5
5
5
7
6
6
5
5
4
% Of Sales
-
3%
3%
4%
4%
5%
4%
6%
5%
5%
5%
General & Admin Exp.
-
12
11
24
13
13
10
10
9
7
5
% Of Sales
-
9%
7%
19%
9%
10%
8%
9%
9%
8%
7%
Selling & Distn. Exp.
-
7
8
5
7
6
6
5
4
4
5
% Of Sales
-
5%
5%
4%
5%
5%
5%
4%
4%
5%
7%
Miscellaneous Exp.
-
3
3
3
12
10
3
5
5
5
5
% Of Sales
-
2%
2%
2%
9%
8%
3%
5%
5%
6%
9%
EBITDA
-1
-2
6
-12
-11
-13
-4
-9
-10
-12
-20
EBITDA Margin
-1%
-1%
4%
-9%
-8%
-10%
-3%
-8%
-10%
-14%
-25%
Other Income
23
24
5
25
6
95
13
3
16
4
9
Interest
3
4
3
3
5
4
10
11
9
10
11
Depreciation
3
3
2
2
4
17
5
3
14
3
3
PBT
16
16
6
8
-14
62
-6
-20
-16
-21
-25
Tax
1
1
4
7
5
14
1
1
1
1
4
Tax Rate
8%
5%
66%
86%
-33%
22%
-12%
-3%
-9%
-11%
-53%
PAT
15
15
2
1
-19
48
-7
-20
-18
-11
-11
PAT before Minority Interest
15
15
2
1
-19
48
-7
-20
-18
-11
-11
Minority Interest
0
0
0
0
0
0
0
0
0
0
0
PAT Margin
12%
12%
1%
1%
-14%
36%
-5%
-19%
-18%
-12%
-14%
PAT Growth
496%
672%
85%
106%
-138%
822%
67%
-12%
-68%
5%
 
EPS
1.96
2.02
0.26
0.14
-2.42
6.28
-0.87
-2.64
-2.35
-1.40
-1.47

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
45
31
27
25
39
-9
-2
18
36
47
Share Capital
77
77
77
77
77
77
77
77
77
77
Total Reserves
-32
-46
-50
-51
-38
-86
-79
-59
-40
-29
Non-Current Liabilities
5
9
11
6
13
15
59
17
16
21
Secured Loans
5
9
11
5
6
6
3
4
3
13
Unsecured Loans
0
0
0
0
0
0
0
0
0
9
Long Term Provisions
3
4
4
6
7
10
56
12
12
0
Current Liabilities
133
171
155
124
153
163
155
175
171
172
Trade Payables
40
47
40
29
27
28
28
21
33
32
Other Current Liabilities
66
91
80
50
57
92
86
74
66
71
Short Term Borrowings
24
29
30
35
40
39
37
33
25
0
Short Term Provisions
4
4
5
10
29
4
3
47
47
69
Total Liabilities
183
211
193
155
204
169
211
210
223
241
Net Block
57
58
59
72
72
91
94
98
111
112
Gross Block
68
66
65
76
138
154
152
155
156
154
Accumulated Depreciation
11
8
6
4
66
63
58
56
45
42
Non Current Assets
79
95
80
82
92
100
144
106
123
116
Capital Work in Progress
0
24
14
3
9
1
0
0
0
1
Non Current Investment
18
9
5
5
8
1
1
1
2
2
Long Term Loans & Adv.
2
2
1
2
2
8
48
3
3
0
Other Non Current Assets
1
2
0
0
1
0
0
3
6
0
Current Assets
104
116
114
73
112
68
67
105
100
125
Current Investments
0
0
0
0
0
0
0
0
0
0
Inventories
16
15
14
14
14
17
15
14
12
10
Sundry Debtors
29
35
34
29
30
25
27
28
22
32
Cash & Bank
22
23
22
17
16
14
12
7
9
18
Other Current Assets
37
16
25
2
51
12
13
56
57
66
Short Term Loans & Adv.
26
27
18
11
38
11
11
55
55
66
Net Current Assets
-30
-55
-42
-51
-40
-94
-87
-70
-70
-47
Total Assets
183
211
193
155
204
169
211
210
223
241

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
-7
19
-7
5
-75
-8
11
-3
-13
-3
PBT
15
8
8
-14
62
-6
-20
-16
-10
-11
Adjustment
-13
2
-12
18
-67
2
14
7
-2
1
Changes in Working Capital
-6
17
16
3
-64
0
18
8
9
11
Cash after chg. in Working capital
-4
27
13
7
-70
-4
13
-1
-3
0
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
-2
-8
-20
-2
-5
-4
-2
-2
-10
-3
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
17
-9
18
-3
80
10
-1
0
11
8
Net Fixed Assets
0
0
1
57
21
0
1
2
1
9
Net Investments
3
0
9
7
-27
0
2
0
-2
-13
Others
15
-9
8
-67
86
10
-4
-3
11
12
Cash from Financing Activity
-14
-6
-2
-6
-3
-1
-8
3
1
-4
Net Cash Inflow / Outflow
-4
3
8
-4
2
1
2
-1
-1
1
Opening Cash & Equivalents
17
14
5
10
8
8
6
7
8
17
Closing Cash & Equivalent
13
17
14
5
10
8
8
6
7
18

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
6
4
3
3
5
-1
0
2
5
6
ROA
8%
1%
1%
-10%
26%
-4%
-10%
-8%
-5%
-5%
ROE
41%
7%
4%
-58%
328%
0%
-256%
-66%
-26%
-21%
ROCE
27%
13%
16%
-12%
107%
10%
-18%
-13%
0%
6%
Fixed Asset Turnover
2.06
2.34
1.77
1.27
0.93
0.83
0.70
0.66
0.59
0.53
Receivable days
84
82
92
79
75
75
94
88
107
122
Inventory Days
42
35
41
38
43
46
49
46
45
44
Payable days
128
118
109
82
72
85
87
88
128
131
Cash Conversion Cycle
-2
-1
23
35
45
36
56
47
23
35
Total Debt/Equity
0.67
1.31
1.63
1.67
1.22
-4.94
-19.21
2.17
0.81
0.45
Interest Cover
6
3
3
-2
16
0
-1
-1
0
0

Annual Reports:

Financial Year 2019
Financial Year 2018
Financial Year 2017
Financial Year 2016
Financial Year 2015
Financial Year 2014
Financial Year 2013
Financial Year 2012
Financial Year 2011

News Update


No Latest News!

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.